Literature DB >> 8218235

DNA conformational change produced by the site-specific interstrand cross-link of trans-diamminedichloroplatinum(II).

V Brabec1, M Síp, M Leng.   

Abstract

The DNA distortion produced by the interstrand cross-link of trans-diamminedichloroplatinum-(II) has been described by means of gel electrophoresis, chemical probes, and molecular mechanics modeling. Synthetic double-stranded oligodeoxyribonucleotides of varying lengths (19-22 base pairs) were synthesized that contained a unique site-specific interstrand cross-link within their central sequence d(TGCT)/d(AGCT) between complementary guanine and cytosine residues. We find that the platinated deoxyriboguanosine residue adopts syn conformation. The duplex is distorted on both sides of the cross-link, but the bases are still paired. The distortion introduces some flexibility into the helix. In addition, the double helix is unwound and bent toward the major groove.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8218235     DOI: 10.1021/bi00094a025

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  25 in total

1.  Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog.

Authors:  Jaroslav Malina; Olga Novakova; Marie Vojtiskova; Giovanni Natile; Viktor Brabec
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

2.  Geometry matters: inverse cytotoxic relationship for cis/trans-Ru(ii) polypyridyl complexes from cis/trans-[PtCl2(NH3)2].

Authors:  Erin Wachter; Ana Zamora; David K Heidary; José Ruiz; Edith C Glazer
Journal:  Chem Commun (Camb)       Date:  2016-08-09       Impact factor: 6.222

3.  Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.

Authors:  Hana Kostrhunova; Jaroslav Malina; Amanda J Pickard; Jana Stepankova; Marie Vojtiskova; Jana Kasparkova; Tereza Muchova; Matthew L Rohlfing; Ulrich Bierbach; Viktor Brabec
Journal:  Mol Pharm       Date:  2011-08-17       Impact factor: 4.939

4.  Thermodynamic stability and energetics of DNA duplexes containing major intrastrand cross-links of second-generation antitumor dinuclear Pt(II) complexes.

Authors:  Jakub Florian; Jana Kasparkova; Nicholas P Farrell; Viktor Brabec
Journal:  J Biol Inorg Chem       Date:  2011-09-06       Impact factor: 3.358

5.  DNA interactions of antitumor cisplatin analogs containing enantiomeric amine ligands.

Authors:  J Malina; C Hofr; L Maresca; G Natile; V Brabec
Journal:  Biophys J       Date:  2000-04       Impact factor: 4.033

6.  Steric control of DNA interstrand cross-link sites of trans platinum complexes: specificity can be dictated by planar nonleaving groups.

Authors:  V Brabec; K Neplechova; J Kasparkova; N Farrell
Journal:  J Biol Inorg Chem       Date:  2000-06       Impact factor: 3.358

7.  DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2].

Authors:  V Brabec; O Vrána; O Nováková; V Kleinwächter; F P Intini; M Coluccia; G Natile
Journal:  Nucleic Acids Res       Date:  1996-01-15       Impact factor: 16.971

8.  Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin.

Authors:  Jana Kasparkova; Miroslav Fojta; Nicholas Farrell; Viktor Brabec
Journal:  Nucleic Acids Res       Date:  2004-10-14       Impact factor: 16.971

9.  Biophysical studies on the stability of DNA intrastrand cross-links of transplatin.

Authors:  Jana Kasparkova; Victoria Marini; Vendula Bursova; Viktor Brabec
Journal:  Biophys J       Date:  2008-08-01       Impact factor: 4.033

10.  Factors affecting DNA-DNA interstrand cross-links in the antiparallel 3'-3' sense: a comparison with the 5'-5' directional isomer.

Authors:  Rasha A Ruhayel; Joseph J Moniodis; Xiaohong Yang; Jana Kasparkova; Viktor Brabec; Susan J Berners-Price; Nicholas P Farrell
Journal:  Chemistry       Date:  2009-09-21       Impact factor: 5.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.